Status:
COMPLETED
Effect of Probiotics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Lead Sponsor:
ImmuneBiotech Medical Sweden AB
Collaborating Sponsors:
Karolinska Institutet
Conditions:
Myalgic Encephalomyelitis
Chronic Fatigue Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a neurological disease. Currently there is no effective treatment for ME/CFS due to unclear etiology of the disease. The aim of this rand...
Detailed Description
Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) is a neurological disease with different symptoms such as fatigue. Symptoms get worse by physical or mental exertion which usually persists...
Eligibility Criteria
Inclusion
- Clinical diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) at Stora Sköndals Neurological Rehabilitation Clinic
- Gastrointestinal complications similar to IBS
Exclusion
- Consumption of any probiotics two weeks before enrolment
- Consumption of other probiotic products during the trial
Key Trial Info
Start Date :
March 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04741841
Start Date
March 30 2020
End Date
June 30 2021
Last Update
October 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurological Rehabilitation Clinic in Stora Sköndal
Stockholm, Sweden